• Profile
Close

Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis

BMC Cancer Jul 30, 2021

Li J, Cao J, Li P, et al. - This study was intended to construct and validate an mRNA-based signature for predicting the prognosis of patients with bladder cancer. Researchers downloaded RNA-seq data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus. They screened differentially expressed genes in three datasets, and prognostic genes were distinguished from the training set of TCGA dataset. They constructed an mRNA-based signature that incorporated clinical prognostic parameters to prognosticate bladder cancer (BC) patient prognosis well, which may provide a novel prognosis assessment tool for clinical practice and evaluate several potential novel biomarkers related to the prognosis of patients with BC.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay